Hero

Press Releases

Press Releases

Royalty Pharma to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

NEW YORK, NY, June 8, 2022 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the Goldman Sachs 43 rd Annual Global Healthcare Conference on June 14, 2022 at 2:20 p.m. ET.

Royalty Pharma to Present at the UBS Global Healthcare Conference 2022

NEW YORK, NY, May 23, 2022 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the UBS Global Healthcare Conference 2022 on May 24, 2022 at 1:15 p.m. ET. The webcast will be accessible from Royalty

Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Unique Business Model to Drive Value for All Stakeholders

NEW YORK, NY, May 17, 2022 – Royalty Pharma plc (Nasdaq: RPRX) will host its inaugural Investor Day in New York City today. Royalty Pharma’s management team will provide an update on the company’s capital deployment

Royalty Pharma Announces Charitable Alliance with Mount Sinai

Establishes Mount Sinai-Royalty Pharma Alliance for Health Equity Research in collaboration with the Institute for Health Equity Research Alliance will support innovative, sustainable initiatives and policies that address systemic inequities in health care NEW YORK, NY, May 16, 2022 - Royalty

Royalty Pharma Reports First Quarter 2022 Results

NEW YORK , NY,  May 05, 2022 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2022 and reaffirmed full-year 2022 guidance for Adjusted Cash Receipts(1) (a non-GAAP financial measure).

Royalty Pharma Declares Second Quarter 2022 Dividend

NEW YORK, NY, April 18, 2022 – The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2022 of $0.19 per Class A ordinary share. The dividend will be paid on June 15, 2022, to shareholders of record at the close of business on May

Royalty Pharma to Announce First Quarter 2022 Financial Results on May 5, 2022

NEW YORK, NY, April 13, 2022 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2022 financial results on Thursday, May 5, 2022 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m.

Royalty Pharma Announces Charitable Alliance with the Leukemia & Lymphoma Society (LLS)

NEW YORK, NY and RYE BROOK, NY, March 28, 2022 – Royalty Pharma plc (Nasdaq: RPRX) today announced a charitable commitment totaling $7.5 million to The Leukemia & Lymphoma Society (LLS), a global leader in the fight against blood cancer.

Royalty Pharma to Present at Cowen’s 42nd Annual Health Care Conference

NEW YORK, NY, March 3, 2022 – Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at Cowen’s 42nd Annual Health Care Conference on March 8, 2022 at 11:10 a.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at

Royalty Pharma Announces Inaugural Investor Day

NEW YORK, NY, February 16, 2022 Royalty Pharma plc (Nasdaq: RPRX) today announced that it will host an inaugural Investor Day in New York City on Tuesday, May 17, 2022, starting at 8:30 a.m. ET. Royalty Pharma senior executives will present on the outlook for royalty funding in life sciences
Displaying 1 - 10 of 98